Oaktree Acquisition Corp. Class A OAC 深 沪
已收盘 01-20 16:00:00 美东时间
16.38
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 16.38
- 总市值 4.12亿
- 52周最高 18.81
- 市盈率 静 30.78
- 换手率 0.00%
- 52周最低 9.40
- 委 比 0.00%
- 总股本 2515.63万
- 历史最高 18.81
- 量 比 0
- 振 幅 0.00%
- 历史最低 9.40
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多斯蒂芬·罗奇：美股科技七巨头泡沫令人担忧，比特币等加密货币是“定时炸弹”
在美国政局日益复杂、美元指数持续走软的背景下，美元是否会失去其全球储备货币的地位？美股持续上涨，“美国科技七巨头”泡沫何时破灭？ 10月23日，在2025外滩年...
10-24 15:34
靖因药业闯关港交所：技术光环下的资本博弈与IPO前路
近日，成立仅四年的创新生物技术公司靖因药业（Sirius Therapeutics）正式向港交所递交上市申请，高盛、海通国际、汇丰联袂担任联席保荐人。 这家聚...
10-21 20:39
Cybin Highlights Neuropsychiatry Platform And Upcoming Clinical Milestones; Completes Enrollment Of 36 Participants In Phase 2 Study Of CYB004; Continues To Advance CYB003, The Company's Proprietary Deuterated Psilocin Analog, In Phase 3 Studies For The Adjunctive Treatment Of Major Depressive Disorder; Dosing Is Ongoing In The First Pivotal Study, APPROACH , With Expected Enrollment Of 220 Patients Across 45 U.S. Clinical Sites
- Successfully completed enrollment of 36 participants in Phase 2 study of CYB004, the Company's deuterated dimethyltryptamine ("DMT") program for the treatment of Generalized Anxiety Disorder ("GAD"). Topline data
09-24 05:16
CytoSorbents Provides DrugSorb-ATR Regulatory Update
PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surge...
09-16 19:00
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Option...
09-13 22:10
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
PRINCETON, N.J., Sept. 5, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surger...
09-05 19:00
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization PRINCETON, N.J., Aug. 20, 20...
08-20 19:00
Super Micro Computer Q4 FY2025 Earnings Call Transcript
Super Micro Computer Inc.(NASDAQ:SMCI) reported fourth-quarter financial ...
08-06 06:13
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and...
07-02 19:00
别再盯着美股了 2021年这些国家的股市更具潜力
2021年可能是国际投资盛行的一年。 上周四，有三位市场分析师接受了外媒采访，表示2021年外国股票有机会跑赢美国股票。年初至今，除美国外的发达市场和新兴市场的...
2021-01-25 22:30
